PerkinElmer, Inc. Introduces Signature Precision Panel(TM) Prenatal Diagnostic Test for Rapid Detection of Genetic Abnormalities During Pregnancy
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that the Company’s Signature Genomics Laboratories has launched its new Signature Precision Panel™| Prenatal diagnostic test for rapid testing of 15 common and severe chromosomal disorders.